Heliox Market Size, Share & Trends Analysis Report By Product (79/21(Helium/Oxygen mixtures), 70/30(Helium/Oxygen mixtures), 60/40(Helium/Oxygen mixtures) & 90/10(Helium/Oxygen mixtures)), By Applications (Medical Uses, Diving Uses), By End Use, By Region, and Segment Forecasts - 2035

Heliox Market Overview

The global heliox market size was valued at USD 30034.96 million in 2025 and is projected to grow from USD 30680.71 million in 2026 to USD 32702.47 million by 2035, exhibiting a CAGR of 2.15% during the forecast period.

The Heliox Market in 2026 is characterized by specialized respiratory-care demand, expanding medical-gas infrastructure, deep-diving requirements, helium supply-security initiatives, and increased emphasis on precisely controlled oxygen concentrations. Among the supplied Product Types, 70/30(Helium/Oxygen mixtures) is estimated to account for approximately 41% of market demand, followed by 79/21(Helium/Oxygen mixtures) at around 30%, 60/40(Helium/Oxygen mixtures) at approximately 19%, and 90/10(Helium/Oxygen mixtures) at around 10%. Medical Uses dominate with an estimated 76% Application share, while Diving Uses represent approximately 24%. Heliox provides a lower-density breathing mixture than conventional air because helium is substantially less dense than nitrogen. This physical characteristic can reduce turbulent resistance during airflow through narrowed airways, making selected mixtures useful as supportive respiratory gases. A 70/30 mixture contains 70% helium and 30% oxygen, while the 79/21 configuration provides an oxygen fraction close to atmospheric oxygen concentration. Higher oxygen mixtures such as 60/40 sacrifice some helium-related density advantage but provide greater oxygen concentration for patients requiring more supplemental oxygen. Medical-gas suppliers increasingly focus on cylinder traceability, mixture accuracy, pressure regulation, purity verification, and hospital delivery reliability because heliox remains a specialized product requiring controlled handling.

The United States represents an important Heliox Market because of its extensive hospital infrastructure, respiratory-care capabilities, specialty gas distribution, critical-care systems, emergency medicine, and commercial diving activity. North America is estimated to account for approximately 36% of global market demand in 2026. 70/30(Helium/Oxygen mixtures) represents around 43% of regional Product Type demand, 79/21(Helium/Oxygen mixtures) contributes approximately 29%, 60/40(Helium/Oxygen mixtures) represents 20%, and 90/10(Helium/Oxygen mixtures) accounts for around 8%. Medical Uses contribute approximately 81% of regional demand, while Diving Uses represent around 19%. Heliox is generally positioned as supportive rather than universal respiratory therapy and is considered in situations involving narrowed upper or large airways where reduced gas density can lower resistance. The U.S. supply environment is also influenced by the strategic importance of helium across healthcare, semiconductor manufacturing, aerospace, research, and MRI systems. Industrial-gas suppliers have therefore increased investment in helium sourcing, reserves, logistics, and long-term contracts. Reliable cylinder availability is especially important because a hospital using heliox during acute respiratory care may require immediate access rather than depending on long replenishment cycles.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: 70/30(Helium/Oxygen mixtures) is estimated to hold approximately 41% market share, supported by its balance between lower-density helium content and a 30% oxygen concentration for Medical Uses.
• Leading Application: Medical Uses are estimated to account for approximately 76% of market demand as hospitals and respiratory-care facilities utilize heliox for selected airway-obstruction and breathing-support situations.
• Leading Region: North America is estimated to represent approximately 36% market share, supported by advanced hospital infrastructure, established medical-gas distribution, specialty respiratory care, and commercial diving operations.
• Fastest Growing Region: Asia-Pacific is projected to expand at approximately 3.6% annually as hospital gas infrastructure, specialty healthcare, offshore operations, and industrial-gas distribution networks broaden.
• Technology Trend: Modern gas-production and analysis systems increasingly control specialty-gas composition within tolerances approaching 1% of target concentration, strengthening mixture consistency and clinical reliability.
• Market Driver: Respiratory care remains the primary driver as a 70/30 mixture provides 30% oxygen while maintaining a helium-dominant composition that reduces gas density compared with air.
• Competitive Landscape: Helium suppliers are strengthening sourcing security, including long-term agreements covering approximately 3 million cubic meters of high-purity helium annually for global distribution.
• Future Outlook: Medical-gas infrastructure investment will remain important as major suppliers are expanding cylinder-filling facilities capable of handling close to 1,000 cylinders per day at selected locations.

Latest Trends

One of the strongest trends in the Heliox Market is greater integration of specialty respiratory gases into modern hospital gas-management systems. Medical Uses represent approximately 76% of Application demand, and suppliers increasingly emphasize standardized mixtures, digital cylinder tracking, pressure-control equipment, staff training, and verified gas composition. The 70/30(Helium/Oxygen mixtures) segment leads with approximately 41% share because its 30% oxygen concentration can provide more oxygen than ambient air while preserving substantial helium content. 79/21(Helium/Oxygen mixtures) provides approximately 21% oxygen and maximizes helium concentration among commonly used medical-oriented mixtures within the supplied segmentation. Hospitals are increasingly incorporating specialty gases into centralized procurement programs rather than treating them as isolated cylinder purchases. This allows facilities to monitor stock levels, expiry-related controls, cylinder location, and usage patterns more effectively. Medical-gas suppliers are also developing lower-carbon supply approaches across their broader healthcare portfolios. Several large gas providers now combine specialty gas distribution with respiratory home care, hospital infrastructure, oxygen systems, and digital inventory management, increasing the strategic relevance of integrated service contracts.

A second major trend is stronger focus on helium supply resilience. Helium is a finite and geographically concentrated resource, and the same supply chain supports healthcare, electronics, aerospace, scientific research, fiber optics, MRI equipment, and specialty gas markets. Because heliox contains between 60% and 90% helium across the supplied Product Types, availability and procurement costs are directly linked to helium sourcing conditions. Industrial-gas companies are increasingly securing multi-year supply agreements, developing storage capability, diversifying geographic sources, and acquiring strategic helium assets. One major 2025 supply agreement covered approximately 3 million cubic meters of high-purity helium annually, illustrating the scale of long-term procurement required by global gas distributors. Greater supply diversification reduces exposure to disruption from individual production regions or transportation routes. Diving Uses, accounting for approximately 24% of market demand, are also sensitive to helium availability because deeper commercial and technical diving can consume significant gas volumes. Operators increasingly use gas-recovery planning and optimized blending to reduce unnecessary helium loss during complex diving programs.

Market Dynamics

Driver

""Specialized respiratory care continues to support demand for helium-rich breathing mixtures.""

The primary Heliox Market driver is the need for specialized breathing mixtures in selected respiratory-care situations. Medical Uses account for approximately 76% of demand because helium's low density can reduce resistance when gas moves through narrowed airways. A 70/30 mixture contains 70% helium and 30% oxygen, while 79/21 contains 79% helium and 21% oxygen. These concentrations allow clinicians to select different balances between oxygen delivery and the physical airflow advantages associated with helium. Heliox is generally used as supportive therapy rather than as a replacement for definitive treatment, but its specialized characteristics maintain demand in hospitals with respiratory, emergency, pediatric, and critical-care capabilities.

Healthcare infrastructure expansion reinforces this driver. Large medical-gas companies provide oxygen, helium mixtures, respiratory equipment, cylinders, manifolds, and technical services to thousands of healthcare facilities. A single regional cylinder-filling facility can be designed to process close to 1,000 cylinders per day, improving availability across hospitals and clinics. Medical-gas reliability becomes especially important because urgent respiratory requirements can develop rapidly. This supports investment in inventory planning, filling infrastructure, emergency delivery, backup cylinder stocks, and quality-control systems.

Restraint

""Helium supply constraints and specialized clinical requirements limit broad routine adoption.""

The largest market restraint is helium availability and cost. Every supplied Product Type contains at least 60% helium, while 90/10(Helium/Oxygen mixtures) contains 90%. Helium competes for supply with MRI cooling, semiconductor manufacturing, aerospace, laboratories, quantum technology, and other high-value applications. Supply disruptions or transportation constraints can therefore affect heliox procurement even when medical demand remains stable. Hospitals may maintain only limited quantities because heliox is used selectively rather than continuously across all respiratory patients.

Clinical limitations provide another restraint. Increasing the oxygen percentage reduces the proportion of helium and therefore reduces some of the density advantage that defines the mixture. A 60/40 blend contains twice the oxygen concentration of approximately atmospheric levels but only 60% helium. Patients requiring very high oxygen concentrations may therefore obtain less benefit from helium-rich mixtures. This trade-off restricts heliox to specific clinical situations and prevents the product from becoming a routine replacement for conventional oxygen therapy.

Opportunity

""Expanding specialty-gas infrastructure in emerging markets creates additional distribution opportunities.""

Asia-Pacific presents a significant opportunity as hospitals, offshore industries, medical-gas networks, and cylinder-filling infrastructure expand. The region is projected to grow at approximately 3.6% annually, faster than the overall Heliox Market. Major industrial-gas companies are investing in new production and cylinder-filling sites across countries such as India and China. One planned filling center in western India is designed for nearly 1,000 cylinders per day, demonstrating the scale of infrastructure being added to support industrial and medical gas customers.

Diving Uses provide another opportunity in offshore energy, subsea engineering, marine construction, underwater inspection, and specialized technical diving. Helium-oxygen mixtures can reduce nitrogen-related limitations during deeper operations. A 90/10 mixture contains 90% helium and 10% oxygen and is therefore relevant only under specialized pressure and diving conditions where oxygen partial pressure is carefully controlled. Offshore operators increasingly require precisely blended gases, documented composition, safe cylinder handling, and reliable logistics, creating opportunities for specialty-gas suppliers with marine distribution capabilities.

Challenge

""Precise blending and application-specific oxygen requirements create demanding quality-control obligations.""

The main technical challenge is maintaining the correct helium-to-oxygen ratio across production, filling, storage, delivery, and administration. The difference between 79/21 and 70/30 represents a 9-percentage-point change in both helium and oxygen concentration, materially altering the breathing mixture. Gas suppliers therefore rely on calibrated analyzers, controlled blending systems, cylinder identification, batch documentation, and quality assurance to prevent composition errors. Medical applications also require equipment compatible with the physical properties of helium-rich gases.

Diving applications add another layer of complexity because oxygen suitability depends on operating depth and pressure. A mixture containing 10% oxygen may be inappropriate at the surface but usable under selected hyperbaric conditions where increased ambient pressure raises oxygen partial pressure. Conversely, a 40% oxygen mixture creates different exposure constraints. Commercial diving operations therefore require strict gas planning, depth calculations, backup-gas procedures, and trained personnel. This limits the market to organizations capable of maintaining sophisticated safety systems.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

79/21(Helium/Oxygen mixtures): 79/21(Helium/Oxygen mixtures) are estimated to represent approximately 30% market share. The mixture contains 79% helium and 21% oxygen, providing the highest helium concentration among the supplied mixtures commonly aligned with approximately atmospheric oxygen concentration. Its lower density relative to air can reduce turbulent airflow resistance under appropriate conditions. The mixture is relevant to selected Medical Uses where substantial supplemental oxygen is not required and to specialized Diving Uses where oxygen partial pressure is managed according to depth. Its 79% helium content also makes the segment particularly sensitive to helium procurement conditions.

70/30(Helium/Oxygen mixtures): 70/30(Helium/Oxygen mixtures) lead with approximately 41% market share because they provide 30% oxygen while maintaining a 70% helium concentration. This balance supports broad medical familiarity in selected respiratory-care applications. The mixture is commonly supplied in compressed cylinders and requires compatible regulators and flow-control equipment. Compared with a 79/21 mixture, oxygen concentration rises by approximately 43%, while helium concentration decreases by about 11%. This trade-off makes 70/30 particularly relevant where additional oxygen is needed without eliminating the low-density characteristics of a helium-rich breathing gas.

60/40(Helium/Oxygen mixtures): 60/40(Helium/Oxygen mixtures) account for approximately 19% market share and address situations requiring a higher oxygen concentration. The mixture provides 40% oxygen and 60% helium, giving almost twice the oxygen fraction of ordinary atmospheric air. The reduced helium percentage means the density advantage is less pronounced than in 70/30 or 79/21, but the higher oxygen concentration can be important for selected Medical Uses. Accurate blending is essential because a deviation of only several percentage points can materially alter delivered oxygen concentration.

90/10(Helium/Oxygen mixtures): 90/10(Helium/Oxygen mixtures) represent approximately 10% market share and have their strongest relevance in specialized Diving Uses rather than conventional surface medical therapy. The mixture contains 90% helium and only 10% oxygen, meaning oxygen partial pressure must be considered carefully according to ambient pressure. Its very high helium concentration helps reduce nitrogen exposure and gas density during deeper operations. Because helium represents 9 out of every 10 volume units, this segment is particularly exposed to helium supply availability and gas-recovery economics.

By Applications

Medical Uses: Medical Uses dominate with approximately 76% market share. Heliox is employed as supportive respiratory gas in selected cases involving airway narrowing, obstruction, or increased breathing effort. The 70/30 mixture holds a strong position because its 30% oxygen concentration can support patients requiring more oxygen than atmospheric air while preserving helium as the majority gas. Medical applications require controlled cylinders, compliant regulators, clearly differentiated labels, gas analysis, trained staff, and documented handling procedures. Hospital demand tends to be lower-volume but higher-value and more quality-sensitive than many industrial gas applications.

Diving Uses: Diving Uses account for approximately 24% market share and include commercial, offshore, technical, scientific, and specialized underwater operations. Helium-oxygen mixtures reduce reliance on nitrogen during deeper diving. 90/10 and 79/21 mixtures have particular relevance where operating pressure modifies the effective oxygen partial pressure. Deep-diving projects can consume dozens or hundreds of cylinders depending on team size, depth, duration, and whether closed or open breathing systems are used. Gas recovery and recycling become increasingly important because helium can represent up to 90% of the supplied mixture.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to lead the Heliox Market with approximately 36% global share in 2026. Praxair and Air Products and Chemicals, Inc provide supplied-company representation from the United States, while other international gas specialists maintain extensive regional operations. 70/30(Helium/Oxygen mixtures) represent approximately 43% of regional Product Type demand, 79/21(Helium/Oxygen mixtures) account for 29%, 60/40(Helium/Oxygen mixtures) represent 20%, and 90/10(Helium/Oxygen mixtures) contribute around 8%. Medical Uses account for approximately 81% of regional demand.

The region is projected to expand approximately 1.8-2.3% annually through 2035. Mature hospital infrastructure supports specialty respiratory gas availability, while the Gulf of Mexico and other marine industries contribute Diving Uses. Helium supply security is strategically important because the United States has historically maintained extensive storage and distribution infrastructure. Recent industry investments have added helium inventories and procurement flexibility, reducing dependence on individual supply routes. Medical facilities increasingly expect suppliers to maintain 24-hour emergency delivery capability and redundant cylinder stocks.

Europe

Europe represents approximately 29% of global Heliox Market demand. Air Liquide from France and Messer Group from Germany provide major supplied-company representation. 70/30(Helium/Oxygen mixtures) account for approximately 42% of regional Product Type demand, 79/21(Helium/Oxygen mixtures) contribute 31%, 60/40(Helium/Oxygen mixtures) represent 20%, and 90/10(Helium/Oxygen mixtures) account for around 7%. Medical Uses represent approximately 83% of regional Application demand.

The region is projected to expand approximately 1.9-2.5% annually through 2035. Hospital decarbonization and gas-supply optimization are becoming increasingly important procurement factors. Medical-gas suppliers have signed low-carbon gas contracts with more than 20 healthcare institutions across Europe and additional international markets. Large respiratory-care contracts are also expanding; one five-year program awarded in Spain covers approximately 70,000 respiratory patients. These developments strengthen integrated medical-gas distribution networks that can also support specialty mixtures such as heliox.

Asia-Pacific

Asia-Pacific is estimated to account for approximately 23% of global Heliox Market demand in 2026. TAIYO NIPPON SANSO provides strong supplied-company representation from Japan, while Air Liquide, Messer Group, and other international gas companies continue expanding regional infrastructure. 70/30(Helium/Oxygen mixtures) represent approximately 39% of Product Type demand, 79/21(Helium/Oxygen mixtures) contribute 28%, 60/40(Helium/Oxygen mixtures) account for 20%, and 90/10(Helium/Oxygen mixtures) represent around 13%.

Asia-Pacific is projected to grow approximately 3.6% annually through 2035, making it the fastest-growing major region. Japan has established specialty medical-gas and helium infrastructure, while China, India, South Korea, Australia, and Southeast Asia continue expanding advanced healthcare and offshore activity. New cylinder-filling facilities in India are being designed for capacities approaching 1,000 cylinders per day. TAIYO NIPPON SANSO also continues strengthening medical-use oxygen and helium-related activities across Asian markets, supporting broader specialty-gas availability.

Middle East & Africa

Middle East & Africa represent approximately 5% of global Heliox Market demand. 70/30(Helium/Oxygen mixtures) account for approximately 35% of regional demand, 79/21(Helium/Oxygen mixtures) represent 25%, 60/40(Helium/Oxygen mixtures) contribute 17%, and 90/10(Helium/Oxygen mixtures) account for around 23%. Medical Uses represent approximately 61% of regional Application demand, while Diving Uses account for approximately 39%.

The region is projected to grow approximately 3.0-3.5% annually through 2035. Gulf countries combine modern hospital infrastructure with offshore energy and marine industries, creating demand across both supplied Applications. Qatar is particularly important to the broader helium supply chain, with large production facilities supporting international distribution. A 2025 long-term agreement for approximately 3 million cubic meters of high-purity helium per year demonstrated the region's strategic importance to global supply security.

List of Top Heliox Companies

• TAIYO NIPPON SANSO (Japan)
• Praxair (U.S)
• Air Products and Chemicals, Inc (U.S)
• Air Liquide (France)
• Messer Group (Germany)

Top 2 Companies Market Share

Air Liquide: Air Liquide is estimated to represent approximately 21-26% competitive presence among the supplied companies, supported by extensive medical-gas operations, specialty helium mixtures, hospital infrastructure, cylinder distribution, respiratory-care services, and operations across numerous countries. The company supplies 70/30 helium-oxygen mixtures in selected markets and supports healthcare facilities with broader medical-gas systems. Its strategic position aligns with Medical Uses, which represent approximately 76% of overall Heliox Market demand. Recent healthcare investments also include respiratory-care contracts covering approximately 70,000 patients and new cylinder-filling infrastructure capable of approaching 1,000 cylinders per day.

Messer Group: Messer Group is estimated to account for approximately 16-20% competitive presence among the supplied companies, supported by industrial, medical, and specialty-gas operations together with strengthened global helium sourcing. The company secured a long-term agreement in September 2025 covering approximately 3 million cubic meters of high-purity helium annually from Qatar. It also strengthened U.S. helium inventories through strategic asset investments. This sourcing position is particularly relevant because every supplied Heliox Product Type contains between 60% and 90% helium.

Investment Analysis

Investment in the Heliox Market is increasingly concentrated in helium sourcing, storage, gas-analysis systems, cylinder filling, medical-gas distribution, digital inventory tracking, and lower-carbon healthcare supply chains. Helium procurement is especially important because the supplied Product Types contain between 60% and 90% helium. Large industrial-gas suppliers are therefore signing multi-year supply agreements and acquiring helium assets to reduce exposure to global shortages. A single recent agreement secured approximately 3 million cubic meters per year, indicating the scale of supply needed to support diversified industrial, healthcare, and technology customers.

Medical-gas infrastructure represents another investment priority. New regional gas facilities increasingly combine production plants with high-capacity cylinder filling to support hospitals alongside industrial customers. A planned Asian facility includes capacity near 200 tons of gas production per day and approximately 1,000 cylinders per day at its filling center. Heliox suppliers also invest in analyzers capable of confirming mixture composition, specialized valves, pressure regulators, traceability systems, and safety training. Investment through 2035 is expected to concentrate across at least 8 areas: helium sourcing, strategic reserves, blending accuracy, cylinder availability, medical infrastructure, digital tracking, diving support, and supply-chain decarbonization.

New Product Development

New Product Development in the Heliox Market focuses less on introducing entirely new gas molecules and more on improving mixture precision, administration efficiency, packaging, monitoring, and supply reliability. The supplied 79/21, 70/30, 60/40, and 90/10 mixtures address distinct oxygen and helium requirements. Modern filling systems increasingly use automated blending and gas analysis to verify composition before cylinder release. Medical systems are also evolving through improved flowmeters and delivery equipment designed to account for helium's different physical properties. Digital cylinder identification can help hospitals monitor hundreds or thousands of medical-gas cylinders across a large facility.

Diving-focused product development emphasizes high-pressure storage, accurate oxygen analysis, gas reclamation, and improved blending workflows. A 90/10 mixture contains 9 times as much helium as oxygen by volume, making helium recovery economically attractive during high-consumption projects. Commercial diving systems increasingly incorporate closed or semi-closed breathing arrangements where operationally appropriate to reduce gas loss. Across both supplied Applications, new offerings compete across at least 10 characteristics: composition accuracy, purity, cylinder pressure, valve compatibility, regulator performance, traceability, delivery reliability, analysis capability, safety documentation, and helium-source security.

Five Recent Developments

• February 2026: Air Liquide strengthened respiratory-care operations through a 5-year healthcare contract covering approximately 70,000 patients, expanding medical-gas and respiratory-service infrastructure relevant to specialty gas distribution.
• September 2025: Messer Group secured a long-term helium agreement for approximately 3 million cubic meters annually, strengthening global supply security for medical, technology, and specialty-gas customers.
• December 2025: Air Liquide expanded its Indian industrial and healthcare gas footprint through an acquisition covering multiple regional production and specialty-gas activities across 2 major geographic zones.
• July 2025: Air Liquide announced a new Indian gas production and cylinder-filling project with approximately 200 tons per day of production and capacity approaching 1,000 cylinders daily.
• January 2025: Air Liquide expanded lower-carbon medical-gas supply after healthcare agreements reached 20 hospitals and clinics across Europe and Brazil, reinforcing sustainability-focused hospital gas procurement.

Report Coverage

The Heliox Market report covers the 2026-2035 forecast period using the stated 2025 baseline and evaluates the supplied Product Types of 79/21(Helium/Oxygen mixtures), 70/30(Helium/Oxygen mixtures), 60/40(Helium/Oxygen mixtures), and 90/10(Helium/Oxygen mixtures). Estimated Product Type shares are approximately 30%, 41%, 19%, and 10%, respectively. Application coverage includes Medical Uses at approximately 76% and Diving Uses at around 24%. The analysis examines respiratory therapy, airway resistance, oxygen concentration, helium density, specialty gas blending, cylinder filling, hospital distribution, diving gas management, supply security, gas purity, pressure regulation, safety, and helium procurement. The supplied mixture range spans from 60% to 90% helium and from 10% to 40% oxygen, creating distinct performance characteristics for specialized medical and diving requirements.

Regional coverage includes North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with estimated market shares of approximately 36%, 29%, 23%, 7%, and 5%, respectively. Competitive coverage includes all 5 supplied companies: TAIYO NIPPON SANSO, Praxair, Air Products and Chemicals, Inc, Air Liquide, and Messer Group. The report evaluates how respiratory-care infrastructure, hospital specialty-gas demand, helium supply security, deep-diving operations, cylinder-filling capacity, long-term supply contracts, digital traceability, and medical-gas quality standards will influence the Heliox Market through 2035. 70/30(Helium/Oxygen mixtures) remains the leading Product Type at approximately 41% share, while Medical Uses dominate Applications at around 76%. Greater helium-source diversification, automated blending, medical-gas infrastructure, strategic storage, optimized diving consumption, precise gas analysis, digital cylinder management, and lower-carbon supply chains are expected to remain major development priorities throughout the forecast period.